Breaking News
2 hours ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
EMA recommends conditional EU approval for Novartis's Vijoice in PROS, imposing post-marketing study and pharmacovigilance obligations.
Pharma Now Editorial Team

Ionetix becomes the first commercial manufacturer to gain FDA ANDA approval for Ga-68 gozetotide, with a three-hour expiry window driving multi-site GMP complexity.
Pharma Now Editorial Team

60 Degrees Pharmaceuticals reports enrollment one month ahead of schedule in its tafenoquine babesiosis trial, targeting interim analysis by early July 2026.
Pharma Now Editorial Team

China's NMPA clears Boehringer Ingelheim's HERNEXEOS as monotherapy for unresectable, locally advanced or metastatic NSCLC in adults.
Pharma Now Editorial Team
